SEC Form 4 · accession 0000914190-26-000122
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim Kelderman
Officer — Chief Executive Officer · Director
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 5:14 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2026 | M | 21,470 | $0.00 | A | 93,583 | D | |
| Common Stock | Aug 15, 2026 | F | 10,821 | $72.40 | D | 82,762 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Restricted Stock UnitsF2,F3 | — | Aug 15, 2026 | M | 554 | D | — | — | Common Stock | 554 | 8,319 | D |
| Performance Restricted Stock UnitsF2,F3 | — | Aug 15, 2026 | D | 8,319 | D | — | — | Common Stock | 8,319 | 0 | D |
| Performance Stock Options (Right to Buy)F4 | $84.61 | Aug 15, 2026 | D | 22,389 | D | — | Aug 15, 2030 | Common Stock | 22,389 | 1,492 | D |
| Performance Restricted Stock UnitsF2,F7 | — | Aug 15, 2026 | M | 588 | D | — | — | Common Stock | 588 | 8,835 | D |
| Performance Restricted Stock UnitsF2,F7 | — | Aug 15, 2026 | D | 8,835 | D | — | — | Common Stock | 8,835 | 0 | D |
| Performance Stock Options (Right to Buy)F8 | $68.54 | Aug 15, 2026 | D | 24,324 | D | — | Feb 1, 2031 | Common Stock | 24,324 | 1,621 | D |
| Restricted Stock UnitsF2,F11 | — | Aug 15, 2026 | M | 8,543 | D | — | — | Common Stock | 8,543 | 8,544 | D |
| Restricted Stock UnitsF2,F14 | — | Aug 15, 2026 | M | 11,785 | D | — | — | Common Stock | 11,785 | 23,569 | D |
| Stock Option (Right to Buy)F1 | $66.97 | holding | — | — | — | — | Aug 5, 2027 | Common Stock | 115,724 | 115,724 | D |
| Stock Option (Right to Buy)F1 | $120.46 | holding | — | — | — | — | Aug 6, 2028 | Common Stock | 25,944 | 25,944 | D |
| Stock Options (Right to Buy)F1 | $94.52 | holding | — | — | — | — | Aug 15, 2029 | Common Stock | 28,940 | 28,940 | D |
| Stock Options (Right to Buy)F5 | $84.61 | holding | — | — | — | — | Aug 15, 2030 | Common Stock | 29,391 | 29,391 | D |
| Stock Options (Right to Buy)F6 | $52.83 | holding | — | — | — | — | Nov 1, 2030 | Common Stock | 38,252 | 38,252 | D |
| Stock Options (Right to Buy)F9 | $68.54 | holding | — | — | — | — | Feb 1, 2031 | Common Stock | 51,890 | 51,890 | D |
| Performance Restricted Stock UnitsF2,F10 | — | holding | — | — | — | — | — | Common Stock | 51,261 | 51,261 | D |
| Stock Options (Right to Buy)F12 | $74.91 | holding | — | — | — | — | Aug 15, 2034 | Common Stock | 69,061 | 69,061 | D |
| Performance Restricted Stock UnitsF2,F13 | — | holding | — | — | — | — | — | Common Stock | 70,708 | 70,708 | D |
| Stock Options (Right to Buy)F15 | $53.60 | holding | — | — | — | — | Aug 15, 2035 | Common Stock | 90,441 | 90,441 | D |
Explanation of responses
- F1Fully exercisable.
- F10Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F118,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
- F12Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.
- F13Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F1411,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.
- F15Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F3On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited.
- F4On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited.
- F5Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
- F6Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
- F7On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited.
- F8On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited.
- F9Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.